A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140-Reference-Cited by-同舟云学术

A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140

Published:2022-09-20 Issue:9 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Ramesh Nachimuthu¹^ORCID,Manohar Prasanth²^ORCID,Eniyan Kandasamy¹,Archana Loganathan¹,Athira Sudarsanan¹,Loh Belinda³^ORCID,Ma Long²,Leptihn Sebastian²⁴⁵^ORCID

Affiliation:

1. Antibiotic Resistance and Phage Therapy Laboratory, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

2. Zhejiang University-University of Edinburgh (ZJU-UoE) Institute, Zhejiang University, Haining, Zhejiang, People’s Republic of China

3. Fraunhofer Institute for Cell Therapy and Immunology (IZI), Department of Antimicrobial Biotechnology, Leipzig, Germany

4. Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

5. University of Edinburgh Medical School, Biomedical Sciences, College of Medicine & Veterinary Medicine, The University of Edinburgh, Edinburgh, United Kingdom

Abstract

Bacteriophages and bacteriophage-derived peptidoglycan hydrolases (endolysins) present promising alternatives for the treatment of infections caused by multidrug resistant Gram-negative and Gram-positive pathogens. In this study, Gp105, a putative lysozyme murein hydrolase from Enterobacter phage myPSH1140 was characterized in silico, in vitro as well as in vivo using the purified protein.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00506-22

Reference34 articles.

1. World Health Organization. 2014. Antimicrobial resistance global report on surveillance: 2014 summary. No. WHO/HSE/PED/AIP/2014.2. World Health Organization, Geneva, Switzerland.

2. Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the Antibacterial Resistance Leadership Group;Bonomo RA;Clin Infect Dis,2017

3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

4. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

5. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Characterization of Phage ZP3 and Its Endolysin LysZP with Antimicrobial Potential against Xanthomonas oryzae pv. oryzae;Viruses;2024-09-11

2. Role of bacteriophages in shaping gut microbial community;Gut Microbes;2024-08-21

3. Biological characterization of the phage lysin AVPL and its efficiency against Aerococcus viridans -induced mastitis in a murine model;Applied and Environmental Microbiology;2024-08-21

4. Genomic and biological characterization of bacteriophages against Enterobacter cloacae, a high-priority pathogen;Virology;2024-07

5. Cell-free supernatant-assisted biogenic silver nanoparticles enhance the antibacterial efficacy of communicating bacterial pathogens;Biotechnology and Bioprocess Engineering;2024-06-21